Corporate GovernanceNov 3, 2026, 08:22 AM
Guardant Health Grants Performance Stock Units to Co-CEOs
AI Summary
Guardant Health's Board approved performance-based restricted stock units (PSUs) for its Co-CEOs, Helmy Eltoukhy and AmirAli Talasaz. Each received 465,413 target PSUs, with vesting tied to the company's total shareholder return (TSR) relative to the S&P 500 over three- and five-year periods. The awards are designed to align executive compensation with long-term stockholder value creation and market-leading performance.
Key Highlights
- Guardant Health grants 465,413 performance-based restricted stock units (PSUs) to each Co-CEO.
- PSUs vest based on relative TSR performance over 3-year (25%) and 5-year (75%) periods.
- Performance targets range from 50% PSU payout at 40th percentile TSR to 250% at 90th percentile.
- Absolute TSR must be positive for any earned shares; capped at 100% if absolute TSR is negative.
- Earned shares subject to post-vest holding requirements of one year for 3-year PSUs and six months for 5-year PSUs.
Price Impact
More from GH